Full Name
Zdraveska, Marija
Vernacular Name
Zdraveska M.
 
Variants
Zdraveska M
M. Zdraveska
Marija Zdraveska
Lazarevska Marija
Lazarevska M
Здравеска Марија
Здравеска М
Лазаревска Марија
Лазаревска М
Marija Zdravevska
 
Main Affiliation
 
Loading... 2 0 5 0 false
Loading... 3 0 5 0 false

Refined By:
Author:  Monreal M
Author:  RIETE Investigators

Results 1-11 of 11 (Search time: 0.015 seconds).

PreviewTitleAuthor(s)Issue DateType
1Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous ThromboembolismRuiz-Artacho P,; Trujillo-Santos J,; López-Jiménez L,; Font C,; Díaz-Pedroche MDC,; Sánchez Muñoz-Torrero JF,; Peris ML,; Skride A,; Maestre A,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2018Article
2Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism.Moustafa F; Giorgi Pierfranceschi M; Di Micco P; Bucherini E; Lorenzo A; Villalobos A; Nieto JA; Valero B; Sampériz ÁL; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
3Development of a Risk Prediction Score for Occult Cancer in Patients With VTEJara-Palomares L,; Otero R,; Jimenez D,; Carrier M,; Tzoran I,; Brenner B,; Margeli M,; Praena-Fernandez JM,; Grandone E,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
4Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.Peris M; Jiménez D; Maestre A; Font C; Tafur AJ; Mazzolai L; Xifre B; Skride A; Dentali F; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
5Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy.Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
6Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis.Tafur AJ,; Caprini JA,; Cote L; Trujillo-Santos J; Del Toro J,; Garcia-Bragado F; Tolosa C,; Barillari G,; Visona A,; Monreal M; RIETE Investigators; Bosevski, M ; Zdraveska M 2017Article
7Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimensTrujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
8Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE RegistryBarillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
9Systolic blood pressure and mortality in acute symptomatic pulmonary embolismQuezada A,; Jiménez D,; Bikdeli B,; Moores L,; Porres-Aguilar M,; Aramberri M,; Lima J,; Ballaz A,; Yusen RD, Monreal M; RIETE investigators.; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2020Article
10Uterine bleeding during anticoagulation in women with venous thromboembolism.Moustafa F,; Fernández S,; Fernández-Capitán C,; Nieto JA,; Pedrajas JM,; Visoná A,; Valero B,; Marchena PJ,; Braester A,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
11Venous thromboembolism in centenarians: Findings from the RIETE registryLacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article